Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cyclo Therapeutics Inc (NASDAQ: CYTH) closed the day trading at $1.18 up 2.61% from the previous closing price of $1.15. In other words, the price has increased by $2.61 from its previous closing price. On the day, 1.44 million shares were traded. CYTH stock price reached its highest trading level at $1.2 during the session, while it also had its lowest trading level at $1.08.
Ratios:
For a better understanding of CYTH, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.01. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 01 ’23 when Rafael Holdings, Inc. bought 4,000,000 shares for $1.25 per share. The transaction valued at 5,000,000 led to the insider holds 6,514,970 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYTH now has a Market Capitalization of 33764992 and an Enterprise Value of 31436458. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.88 while its Price-to-Book (P/B) ratio in mrq is 55.35. Its current Enterprise Value per Revenue stands at 27.908 whereas that against EBITDA is -1.561.
Stock Price History:
Over the past 52 weeks, CYTH has reached a high of $2.12, while it has fallen to a 52-week low of $0.89. The 50-Day Moving Average of the stock is -6.42%, while the 200-Day Moving Average is calculated to be -15.93%.
Shares Statistics:
Over the past 3-months, CYTH traded about 32.51K shares per day on average, while over the past 10 days, CYTH traded about 194660 shares per day. A total of 28.56M shares are outstanding, with a floating share count of 16.59M. Insiders hold about 42.03% of the company’s shares, while institutions hold 10.74% stake in the company. Shares short for CYTH as of 1721001600 were 41582 with a Short Ratio of 1.28, compared to 1718323200 on 11707. Therefore, it implies a Short% of Shares Outstanding of 41582 and a Short% of Float of 0.16999999999999998.
